erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..

mrs cavanagh, from foyle park in londonderry, had a complex medical history of chronic heart and renal failure..

the medical experts are worse. their pretense of idealism knows no limits, and is matched only by their claim to bullet-proof knowledge..

over years of research, scientists discovered that cgrp helps transmit pain signals in the brain.